Khalil Barrage serves as Executive at Protagenic Therapeutics, Inc. ew, where they oversee executive responsibilities. Since joining the company, Khalil Barrage has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 3, 2021 involved exercising options for 150,000 shares valued at $187.5K.
Khalil Barrage currently holds 245,000 shares of Protagenic Therapeutics, Inc. ew (ATRN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Khalil Barrage has been a net neutral trader of ATRN stock. They have purchased $0 and sold $0 worth of shares.
Khalil Barrage's most recent insider trade was on May 3, 2021, when they sold 150,000 shares at $1.25 per share.
Get notified when new Form 4 filings are submitted
| 45,000 |
| $1.75 |
| Discretionary |
| May 3, 2021 | PTIX | $210.0K | Option Exercise | 120,000 | $1.75 | Discretionary |
| May 3, 2021 | PTIX | $56.3K | Option Exercise | 45,000 | $1.25 | Discretionary |
| Aug 8, 2016 | ATRND | $187.5K | Award | 150,000 | $1.25 | Discretionary |
| Jun 17, 2016 | ATRN | $56.3K | Award | 45,000 | $1.25 | Discretionary |